Arkolith/Insider Trading/EW/Form 4

Mistras Theodora

CVP, Chief Financial OfficerEdwards Lifesciences Corp (EW) · full profile →Form 4 · filed Jul 10, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 9, 2026Grant(A)88K—$088K
Jul 9, 2026Grant(A)12K—$0100K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 9, 2026Grant(A)62K—$062K
Jul 9, 2026Grant(A)12K—$012K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001225208-26-006578) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML